Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumors × pralsetinib × Clear all

Sponsor

Conditions

Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Neoplasms, Nerve Tissue 2 Neoplasms, Germ Cell and Embryonal 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Neoplasms 2 Lung Neoplasms 2 Lung Diseases 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Bronchogenic 2 Carcinoma 2 Adenocarcinoma 2 Thyroid Neoplasms 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors 1 Neoplasms, Glandular and Epithelial 1 Multiple Endocrine Neoplasia Type 2a 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Endocrine System Diseases 1 Endocrine Gland Neoplasms 1 Digestive System Neoplasms 1 Digestive System Diseases 1

Interventions

Gemcitabine 5 Paclitaxel 3 Nivolumab 3 cobimetinib 2 atezolizumab 2 Ramucirumab 2 Carboplatin 2 zansecimab 1 tocilizumab 1 tivozanib 1 tislelizumab 1 temsirolimus 1 ridaforolimus 1 plocabulin 1 pevonedistat 1 pembrolizumab 1 pamiparib 1 obinutuzumab 1 necitumumab 1 liposomal doxorubicin 1 lenvatinib 1 glasdegib 1 futuximab 1 demplatin pegraglumer 1 birinapant 1 adavosertib 1 Temozolomide 1 TAK-981 1 Sunitinib 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡